Trimebutine Maleate
Elderly; pregnancy, lactation.
Irritable bowel syndrome, Chronic gastritis
Patients with known hypersensitivity to trimebutine maleate or any excipient.
N/A
Trimebutine Maleate is generally well tolerated. The infrequently reported adverse effects are as follows: a) Gastrointestinal: Dry mouth, foul taste, diarrhea, dyspepsia, epigastric pain, nausea, constipation, b) CNS: Drowsiness, fatigue, dizziness, hot/cold sensations, headache etc.
Trimebutine is a GI motility regulator with antispasmodic properties.
N/A
N/A
Oral Irritable bowel syndrome Adult: 300-600 mg/day in 3 divided doses. Chronic gastritis Adult: 300 mg/day in 3 divided doses. Elderly: Use with caution.
N/A
N/A
May be taken with or without food.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.